DHANUKA2024-10-012024-12-31 DHANUKA2024-10-012024-12-31 DHANUKA2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member DHANUKA2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member DHANUKA2024-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 507717 DHANUKA NA Dhanuka Agritech Limited Equity 2024-04-01 2025-03-31 2025-02-03 2025-01-27 INR Lakhs Third quarter 11:00:00 12:25:00 2025-02-03 2025-02-03 Not applicable Single segment Agrochemicals 2024-10-01 2024-12-31 Unaudited Consolidated 4452721000.00 70132000.00 4522853000.00 1707167000.00 312839000.00 653952000.00 423380000.00 14343000.00 130598000.00 599809000.00 3842086000.00 680767000.00 0.00 680767000.00 156743000.00 -26423000.00 130320000.00 0.00 550447000.00 0.00 0.00 0.00 0.00 550447000.00 0.00 550447000.00 0.00 0.00 0.00 0.00 90157000.00 2 12.25 12.25 0.00 0.00 12.25 12.25 0.00 0.00 0.00 1. The above Unaudited Financial Results were reviewed by the Audit Committee and thereafter approved and taken on record by the Board of Directors in their Meeting held on 3rd February, 2025. The Statutory Auditors of the Company have conducted a Limited Review of the above Financial Results for the quarter and nine months ended 31st December, 2024. 2. Financial Results for all the periods presented have been prepared in accordance with the recognition and measurement principles of Ind AS notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time. 3. The demand of Groups's products depends on monsoon, pest infestation and crop patterns. Hence there may be variations in the Results from one period to another period. 4. The Group has only one reportable Business segment viz. Agro Chemicals . 5. The Board of Directors of Dhanuka Agritech Limited in its meeting held on 7th November, 2023 had approved the Strike off of its wholly owned subsidiary i.e. Dhanuka Chemicals Private Limited (DCPL). DCPL has filed an application for strike-off with the Registrar of Companies (ROC), NCT of Delhi and Haryana. The ROC has approved the strike off and the name of the Company has been struck off with effect from 16th July, 2024 from the Register of the Companies. 6. During the quarter and nine months ended 31st December, 2024, the Company has bought back its 5,00,000 nos. of fully paid up equity shares, representing 1.10% of the total issued and paid up equity share capital of the Company @ Rs. 2000/- per equity share aggregating to an amount of Rs. 100.00 Crores and extinguished those shares on 11th September, 2024. Consequently, Paid up Share Capital has been reduced by Rs.10,00,000. 7. During the quarter ended Dec, 2024, the Company has entered into various agreements with Bayer AG, Germany to acquire international rights to the active ingredients Iprovalicarb and Triadimenol. With this acquisition, Dhanuka plans to expand its footprint in more than 20 countries, including the regions of LATAM, EMEA and Asia including India. 8. The Results can also be viewed at our website www.dhanuka.com and on the website of BSE & NSE where the Company's shares are listed i.e. at www.bseindia.com and www.nseindia.com respectively. Any query from investors can be sent on email at investors@dhanuka.com. Single segment 2024-04-01 2024-12-31 Unaudited Consolidated 15931286000.00 249493000.00 16180779000.00 8001395000.00 1583427000.00 97095000.00 1318569000.00 33198000.00 380107000.00 1862207000.00 13275996000.00 2904783000.00 0.00 2904783000.00 727244000.00 -37041000.00 690203000.00 0.00 2214580000.00 0.00 0.00 0.00 0.00 2214580000.00 0.00 2214580000.00 0.00 0.00 0.00 0.00 90157000.00 2 48.81 48.81 0.00 0.00 48.81 48.81 0.00 0.00 0.00 Other Expenses 599809000.00 Other Expenses 1862207000.00 0.00 0.00 0.00 0.00